IP Library Granted Patent US 8,877,788
Granted Patent B2
US 8,877,788 · App. 13/942,295 · Granted Nov 4, 2014

Allantoin-containing skin cream

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,788
App. No.
13/942,295
Granted
Nov 4, 2014
Kind
B2
Abstract

An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The composition is in the form of an oil-in-water emulsion. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the pH of the composition is from about 5.0 to about 6.0. The composition can further comprise an acidic anionic polymer. A preferred acidic anionic polymer is a carboxypolymethylene polymer. The composition can further comprise a carbohydrate polymer such as galactoarabinan, polygalactose or polyarabinose. The composition can additionally comprise other ingredients such as herbal extracts, an antioxidant component, an emollient component, a chelator, a solvent component, or a preservative component. The composition is useful as a skin protectant.

Claims (24)

1. A composition consisting essentially of an oil-in-water emulsion comprising:

(a) allantoin;

(b) an emulsifier system including beeswax and an anionic emulsifier that is substantially hydrophilic and is soluble in water; and

(c) an acid to adjust the pH of the composition to a pH of about 4.5 to about 5.8,

wherein the allantoin is stable in the composition for 30 days, 60 days, or 90 days at 40° C.

2. The composition of claim 1 , wherein the anionic emulsifier is selected from the group consisting of ammonium lauryl sulfate, sodium laureth sulfate, sodium oleyl succinate, ammonium lauryl sulfosuccinate, sodium dodecylbenzenesulfonate, ammonium laureth sulfate, sodium N-lauryl sarcosinate, sodium lauryl sulfate, and combinations thereof.

3. The composition of claim 2 , wherein the anionic emulsifier sodium lauryl sulfate.

4. The composition of claim 1 , wherein the acid comprises least one organic acid from 2 to 22 carbon atoms.

5. The composition of claim 4 , wherein the at least one organic acid is selected from the group consisting of citric acid, ascorbic acid, glycolic acid, lactic acid, benzoic acid, salicylic acid, and combinations thereof.

6. The composition of claim 1 , wherein the acid comprises least one inorganic acid.

7. The composition of claim 6 , wherein the at least one inorganic acid selected from the group consisting of hydrochloric acid, sulfuric acid, phosphoric acid, and combinations thereof.

8. The composition of claim 1 , wherein the acid comprises at least one organic acid and at least one inorganic acid.

9. The composition of claim 1 , wherein the allantoin is stable in the composition for 30 days at 40° C.

10. The composition of claim wherein the allantoin is stable in the composition for 1 days at 40° C.

11. The composition of claim 1 , wherein the allantoin is stable in the composition for 90 days at 40° C.

12. The composition of claim 1 , wherein the composition further comprises an emollient component.

13. The composition of claim 12 , wherein the emollient component comprises at least one emollient selected from the group consisting of lanolin oil, cetyl alcohol, stearyl alcohol, cod liver oil, butylated hydroxytoluene, and combinations thereof.

14. The composition of claim 1 , wherein the composition further comprises a preservative component.

15. The composition of claim 14 , wherein the preservative component comprises least one preservative selected from the group consisting of methylparaben, ethylparaben, propylparaben, butylparaben, phenoxyethanol, and combinations thereof.

16. The composition of claim 1 , wherein the composition further comprises a chelating agent.

17. The composition of claim 16 , wherein the chelating agent is tetrasodium EDTA.

18. The composition of claim 1 , wherein the composition further comprises a solvent component.

19. The composition of claim 18 , wherein the solvent component comprises at least one solvent selected from the group consisting of propylene glycol, glycerin, butylene glycol, and combinations thereof.

20. The composition of claim 1 , wherein the composition further comprises at least one component selected from the group consisting of fragrance, proteins, humectants, essential oils, vitamins, colorants, hydroxyacids, plant extracts, sunscreens, sodium hyaluronate, lipids, fatty acids, thickeners, panthenol, and combinations thereof.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2023
From: HAYFIN SERVICES LLP
To: SCIODERM, INC.
Reel/Frame 065143/0525 →
SECURITY INTEREST Recorded Oct 6, 2023
From: AMICUS THERAPEUTICS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 065177/0196 →
SECURITY INTEREST Recorded Jul 30, 2020
From: SCIODERM, INC.
To: HAYFIN SERVICES LLP, AS AGENT
Reel/Frame 053356/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2013
From: FARBER, ELLIOTT
To: ALWYN COMPANY, INC.
Reel/Frame 030857/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2013
From: ALWYN COMPANY, INC.
To: SCIODERM, INC.
Reel/Frame 030857/0572 →